U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research that could lead to new medical marijuana products.

“We are considering that, yeah,” Trump told reporters Monday when asked about reports about the impending order.

“A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify. So we are looking at that very strongly.”

Here is what you need to know:

WHAT WOULD THE EXECUTIVE ORDER DO?

Presently, under the U.S. Controlled Substances Act, marijuana is listed as a Schedule I substance like heroin, implying it has high potential for abuse and no medical value.

Story continues below advertisement

The new executive order would move it to the Schedule III classification that includes controlled substances such as codeine, morphine, certain stimulants, and some

The post U.S. may soon reclassify marijuana to allow medical research. What to know appeared first on GrowCola.com.